Evidence map›Paper›PMID 22685342›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2012

The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys.

Daniel F Manvich, Heather L Kimmel, Debra A Cooper, Leonard L Howell

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Serotonin 5-HTFrontiers in neuroscience · 2025
    Article
  2. Article
  3. Evaluation of the 5-HTPharmacological reports : PR · 2023
    Article
  4. Review
  5. Article
  6. Effects of long-term high-fat food or methamphetamine intake and serotonin 2C receptors on reversal learning in female rhesus macaques.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Pharmacological Modulation of 5-HTNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  12. Article
  13. Article
  14. A short history of the 5-HTPsychopharmacology · 2017
    Review
  15. The serotonin 5-HTJournal of psychopharmacology (Oxford, England) · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniel F ManvichYerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Heather L Kimmel
Debra A Cooper
Leonard L Howell
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATESR01DA012514 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2000 to 2014
$5.5M
The mt-DNA mutator mouseZ01DA000517 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HOFFER, BARRY J · 2007 to 2008
$1.1M
Neuropharmacology of Cocaine in Nonhuman PrimatesK02DA000517 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2001 to 2010
$1.1M
Neuropharmacology of Abused Stimulants in Nonhuman PrimatesK05DA031246 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2012 to 2016
$619k
Effects of mGluR2/3 Activation on Cue-Induced Cocaine Relapse in Squirrel MonkeysF31DA026262 · NIDA · EMORY UNIVERSITY · PI MANVICH, DANIEL F. · 2009 to 2010
$59k
Intramural NIH HHS Z01 DA000517NCRR NIH HHS P51RR165NIDA NIH HHS DA12514NIDA NIH HHS F31 DA026262NIDA NIH HHS F31DA026262NIDA NIH HHS K02 DA000517NIDA NIH HHS K05 DA031246NIDA NIH HHS R01 DA012514NIH HHS P51 OD011132NIH HHS P51OD11132
6 · The paper itself

Abstract

Antagonists of the serotonin (5-hydroxytryptamine; 5-HT) type 2C receptor (5-HT(2C)R) are being considered as potential pharmacotherapeutics for various affective disorders, but evidence suggests that these compounds enhance the effects of cocaine and related psychostimulants in rodents. However, the effects of selective 5-HT(2C)R antagonists have not been evaluated in nonhuman primates. The present studies used operant-behavioral and in vivo microdialysis techniques to assess the impact of 5-HT(2C)R antagonism on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press on a fixed-interval schedule of stimulus termination, pretreatment with the highly selective 5-HT(2C)R antagonist 6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride (SB 242084) (vehicle, 0.01-0.1 mg/kg) produced behavioral-stimulant effects alone and interacted with cocaine in an apparently additive manner. In monkeys trained to self-administer intravenous cocaine according to a second-order schedule of drug delivery, SB 242084 (vehicle, 0.03-0.1 mg/kg) modulated cocaine-induced reinstatement of previously extinguished responding and maintained self-administration behavior when substituted for cocaine availability. These studies are the first to assess the direct reinforcing effects of a 5-HT(2C)R-selective antagonist in any species. Finally, in vivo microdialysis studies revealed that pretreatment with SB 242084 (0.1 mg/kg) modulated cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus, of awake subjects. Taken together, the results suggest that SB 242084 exhibits a behavioral profile that is qualitatively similar to other psychostimulants, although its efficacy is modest compared with cocaine. The observed interactions with cocaine and the substitution for cocaine self-administration may be indicative of some degree of abuse potential in humans.

Indexed as

AminopyridinesAnimalsBehavior, AnimalCocaineConditioning, OperantDopamineDrug SynergismIndolesMaleReceptor, Serotonin, 5-HT2CSaimiriSelf AdministrationSerotonin 5-HT2 Receptor AntagonistsSubstance-Related Disorders6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indolineAminopyridinesCocaineDopamineIndolesReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor Antagonists

Identifiers

PMID22685342
PMCPMC3422522
OpenAlexW2147282433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.